Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 126,196,336
  • Shares Outstanding, K 2,035,753
  • Annual Sales, $ 48,300 M
  • Annual Income, $ -8,948 M
  • EBIT $ 12,215 M
  • EBITDA $ 21,815 M
  • 60-Month Beta 0.29
  • Price/Sales 2.51
  • Price/Cash Flow 7.64
  • Price/Book 6.51

Options Overview Details

View History
  • Implied Volatility 24.37% (-2.64%)
  • Historical Volatility 26.51%
  • IV Percentile 9%
  • IV Rank 10.93%
  • IV High 55.70% on 04/10/25
  • IV Low 20.52% on 12/31/25
  • Expected Move (DTE 6) 1.44 (2.32%)
  • Put/Call Vol Ratio 0.21
  • Today's Volume 64,655
  • Volume Avg (30-Day) 29,903
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 611,711
  • Open Int (30-Day) 626,173
  • Expected Range 60.55 to 63.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.47
  • Number of Estimates 6
  • High Estimate 1.59
  • Low Estimate 1.33
  • Prior Year 1.80
  • Growth Rate Est. (year over year) -18.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.54 +15.77%
on 01/21/26
62.05 -0.10%
on 02/06/26
+7.57 (+13.91%)
since 01/06/26
3-Month
45.26 +36.95%
on 11/20/25
62.05 -0.10%
on 02/06/26
+15.36 (+32.94%)
since 11/06/25
52-Week
42.52 +45.79%
on 10/29/25
63.33 -2.12%
on 03/11/25
+4.57 (+7.96%)
since 02/06/25

Most Recent Stories

More News
BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus

BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus

BMY : 61.99 (+4.15%)
Stocks Settle Lower as Tech and Crypto are Routed

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.38%. March...

MSTR : 134.93 (+26.11%)
GOOGL : 322.86 (-2.53%)
ARES : 130.46 (+7.05%)
AAPL : 278.12 (+0.80%)
GLXY : 19.76 (+17.34%)
DDOG : 111.69 (+4.65%)
ALGN : 187.60 (+6.82%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ZNH26 : 112-035s (-0.01%)
MSFT : 401.14 (+1.90%)
TSLA : 411.11 (+3.50%)
Stocks Retreat as Tech Stocks Fall and the US Labor Market Weakens

The S&P 500 Index ($SPX ) (SPY ) today is down -1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.49%. March E-mini S&P futures...

MSTR : 134.93 (+26.11%)
GOOGL : 322.86 (-2.53%)
ARES : 130.46 (+7.05%)
AAPL : 278.12 (+0.80%)
GLXY : 19.76 (+17.34%)
ALGN : 187.60 (+6.82%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ZNH26 : 112-035s (-0.01%)
MSFT : 401.14 (+1.90%)
TSLA : 411.11 (+3.50%)
ESH26 : 6,952.75s (+1.94%)
Stocks Extend Slump as Tech Rout Deepens

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.40%. March E-mini S&P futures...

MSTR : 134.93 (+26.11%)
GOOGL : 322.86 (-2.53%)
ARES : 130.46 (+7.05%)
AAPL : 278.12 (+0.80%)
ADI : 320.45 (-0.52%)
GLXY : 19.76 (+17.34%)
TXN : 221.44 (-1.13%)
ALGN : 187.60 (+6.82%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ZNH26 : 112-035s (-0.01%)
MSFT : 401.14 (+1.90%)
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025

Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025

BMY : 61.99 (+4.15%)
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor Relations website at http://investor.bms.com...

BMY : 61.99 (+4.15%)
Stocks Slip Before the Open as Tech-Led Selloff Continues, Amazon Earnings on Tap

March S&P 500 E-Mini futures (ESH26) are down -0.42%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.55% this morning, pointing to further losses on Wall Street as technology stocks face renewed...

GOOGL : 322.86 (-2.53%)
NVDA : 185.41 (+7.87%)
AVGO : 332.92 (+7.22%)
BNP.FP : 93.180 (+1.30%)
COP : 107.62 (+2.51%)
SHEL.LN : 2,762.224 (-0.26%)
BSX : 76.27 (-1.76%)
SMCI : 34.38 (+11.44%)
ALGN : 187.60 (+6.82%)
ESH26 : 6,952.75s (+1.94%)
BMY : 61.99 (+4.15%)
TSLA : 411.11 (+3.50%)
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi

Soccer Hall-of-Famer is speaking out for the first time about his private battle with lymphoma and treatment with Breyanzi in honor of World Cancer Day ...

BMY : 61.99 (+4.15%)
Bristol-Myers Squibb Earnings: What To Look For From BMY

Bristol-Myers Squibb Earnings: What To Look For From BMY

BMY : 61.99 (+4.15%)
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care

Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually ...

BMY : 61.99 (+4.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers...

See More

Key Turning Points

3rd Resistance Point 65.05
2nd Resistance Point 63.55
1st Resistance Point 62.77
Last Price 61.99
1st Support Level 60.49
2nd Support Level 58.99
3rd Support Level 58.21

See More

52-Week High 63.33
Last Price 61.99
Fibonacci 61.8% 55.38
Fibonacci 50% 52.93
Fibonacci 38.2% 50.47
52-Week Low 42.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar